Latest California Healthline Stories
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
As Care Shifts From Hospital To Home, Guarding Against Infection Falls To Families
Despite a lack of medical training, relatives increasingly are assigned complex, risky medical tasks at home, such as maintaining catheters. If done incorrectly, blood clots, infections, even death can result.
Expertos elaboran nuevas recomendaciones para la detección del cáncer cervical
Un panel de expertos en prevención dice que las mujeres deberían alternar las pruebas de Papanicolau y VPH, en vez de hacerse las dos a la vez.
Prevention Experts Propose Easing Advice On Number Of Cervical Cancer Screenings
A draft recommendation from the U.S. Preventive Services Task Force says women between ages 30 and 65 should get a Pap test every three years or an HPV screening every five years, but they don’t need to do both.
UC Cancer Centers Join Forces To Fight One Of California’s Top Killers
Doctors and researchers at the five University of California centers will pool their expertise and resources to tackle an illness that kills 60,000 Californians each year and costs $14 billion in medical care and lost work days.
Algunos pacientes con cáncer de tiroides pueden retrasar la cirugía
Alrededor de un tercio de los pacientes con un tumor de tiroides de crecimiento lento, llamado cáncer de tiroides papilar, son elegibles para retrasar el tratamiento, según un nuevo estudio.
Some Thyroid Cancer Patients Can Safely Delay Surgery
Study suggests that many small tumors are sleepy, not deadly.
Cáncer: cuando escribir ayuda a sanar
A través de la escritura expresiva, pacientes con cáncer logran canalizar sus miedos y ansiedades, y contar sus historias, en un inédito proceso creativo.
Writing Your Way Through Cancer
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.